Earnings Feed
Start Free
TANDEM DIABETES CARE INC·4

May 22, 4:11 PM ET

Malagueira Joao Paulo Falcao 4

4 · TANDEM DIABETES CARE INC · Filed May 22, 2026

Research Summary

AI-generated summary of this filing

Updated

Tandem Diabetes (TNDM) Director Joao Malagueira Receives RSU Award

What Happened Joao Paulo Falcao Malagueira, a director of Tandem Diabetes Care (TNDM), received a grant of 10,220 restricted stock units (RSUs) on 2026-05-20 and had 8,759 previously granted RSUs vest and convert into shares on 2026-05-21. The reported price for the conversions/transactions is $0, indicating these were non-cash derivative events (award/vesting and conversion), not an open-market cash purchase or sale.

Key Details

  • Transactions reported:
    • 2026-05-20: Grant/Award (A) — 10,220 RSUs @ $0.00 (acquired; derivative)
    • 2026-05-21: Exercise/Conversion (M) — 8,759 shares @ $0.00 (acquired; conversion of vested RSUs)
    • 2026-05-21: Exercise/Conversion (M) — 8,759 shares @ $0.00 (disposed; reported as $0)
  • Shares owned after the transactions: not specified in the provided filing excerpt.
  • Footnotes:
    • F1: Each RSU represents a contingent right to receive one share (or cash in lieu) per the 2023 Long‑Term Incentive Plan.
    • F2: The 10,220 RSUs granted on 2026-05-20 vest on the one‑year anniversary (subject to plan terms).
    • F3: The 8,759 RSUs were originally granted on 2025-05-21 and vested/converted on their one‑year anniversary (2026-05-21).
  • Filing timeliness: Report filed 2026-05-22 for transactions on 2026-05-20/21 — appears to be filed promptly (within required reporting window).

Context

  • These are derivative/compensation events (RSU grant and vesting/conversion), not open-market buys or sales. Conversion of RSUs into shares is routine compensation‑related activity.
  • The matching disposal entry reported at $0 is recorded in the Form 4 but the filing does not specify sale proceeds or the reason for the disposal (e.g., transfer, net settlement, tax withholding); no cash sale value is shown.

Insider Transaction Report

Form 4
Period: 2026-05-20
TANDEM DIABETES CARE INCTNDM
Malagueira Joao Paulo Falcao
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-21+8,759→ 22,458 total
  • Award

    Restricted Stock Unit

    [F1][F2]
    2026-05-20+10,220→ 10,220 total
    → Common Stock (10,220 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F3]
    2026-05-21−8,759→ 0 total
    → Common Stock (8,759 underlying)
Footnotes (3)
  • [F1]Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
  • [F2]Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
  • [F3]On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Signature
/s/ Jerilyn Laskie, Attorney-in-Fact for Joao Paulo Falcao Malagueira|2026-05-22

Documents

3 files